Exhibit 16.1
May 16, 2014
United States Securities and Exchange Commission
100 F Street, N.E.
Washington D.C. 20549
Re: | CorMedix Inc. |
Commission File Number 001-34673
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K of CorMedix Inc. to be filed with the Securities and Exchange Commission on May 16, 2014, and are in agreement with the statements contained under Item 4.01 therein as they relate to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ CohnReznick LLP
Roseland, New Jersey